BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

STD Med, Inc. Med Continues To Grow


5/3/2006 1:29:14 PM

STOUGHTON, Mass., May 3 /PRNewswire/ -- STD Med, Inc. a developer and manufacturer of medical devices based in Stoughton, Massachusetts, announced the buy-back of the minority shareholder interest held by James Lousararian for approximately the past six years and a change to its board of directors, which included the resignation of James Lousararian.

"The family is very pleased to have the Company returned to its prior ownership structure and is looking forward to another fifty years of innovation," said Steven Tallarida, president of STD Med. The Company, founded by Primo Tallarida in 1953 inside the family chicken coupe, has experienced extraordinary growth under the ownership and direction of sons Steven and Jon Tallarida and its senior management.

In less than ten years, STD Med has introduced four new medical device start-up companies.

* Angiolink Corp., a developer of femoral artery closure technology, utilizing a novel staple, was sold to Medtronic, Inc. in November 2004. * Arthrosurface, Inc. based in Franklin, MA, specializes in the repair of early stage cartilage damage. Arthrosurface has developed and received FDA clearance for several of the orthopedic industry's first true "mini" total joint systems. The company's HemiCap System is receiving great clinical acceptance. * Spirus Medical Inc. has developed a revolutionary Endoluminal Advancement System (EAS(TM)) for GI Endoscopy that represents a significant breakthrough by enabling gastroenterologists to perform flexible endoscopy procedures more efficiently. In addition, Spirus is developing other devices incorporating their same proprietary helix technology for use in urological and gynecological procedures. * CardioSolutions is currently in incubation at STD Med. CardioSolutions is developing a minimally invasive heart repair system to treat patients with mitral valve prolapse. Their Mitral Spacer (patent pending) is percutaneously placed into the heart. The company believes this device will create a major breakthrough in mitral valve repair.

Andrea Patisteas, Vice President of Sales & Marketing at STD Med said, "It is our intention to incubate one or more innovative technologies every fourteen to eighteen months."

For further information, contact STD Med, Inc. P.O. Box 420, Stoughton, MA 02072 or call 781-828-4400.

STD Med, Inc.

CONTACT: Andrea Patisteas of STD Med, +1-508-728-0981



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES